Drugs News and Research

RSS

Fraunhofer FIT develops new Zeta software for cell division analysis

At the European Lab Automation Congress, held in Hamburg on June 6 and 7, Fraunhofer FIT demonstrates the new Zeta software for cell division analysis, which we developed for the Bayer Pharma AG. In the quest for new cancer drugs, this software supports the full workflow from cell detection to visualization and exploration.

24 May 2013

Sinovac Beijing receives GMP certificate for its proprietary vaccines

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that Sinovac Beijing, the main operating subsidiary company of Sinovac, obtained the Certificate of Good Manufacturing Practices for Pharmaceutical Products (GMP Certificate) from the China State and Food Administration (CFDA) for its proprietary vaccines, its Haidian district bulk production plants, and its Changping filing and packaging facility.

24 May 2013

Scientists develop new device to test the effects of drugs

Scientists from the University of Southampton have developed a device which records the brain activity of worms to help test the effects of drugs.

24 May 2013

TSRI scientists devise new technique to find therapeutic antibodies

Scientists at The Scripps Research Institute have devised a powerful new technique for finding antibodies that have a desired biological effect. Antibodies, which can bind to billions of distinct targets, are already used in many of the world's best-selling medicines, diagnostics and laboratory reagents.

24 May 2013

Mayo experts provide tips to prevent teen suicide

Suicide is the third-leading cause of death among young people ages 10 to 24. If parents are worried their child may be having suicidal thoughts, it's no time to tiptoe around the question, according to Mayo Clinic experts who have produced two educational videos on suicide prevention for use by media outlets, schools and others.

24 May 2013

New research identifies mechanism to make cancer cells respond to chemotherapy

Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University explains why some cancer cells don't respond to chemotherapy, and identifies a mechanism to rectify that.

24 May 2013

Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added heart toxicity, according to the results of a study published online today in Blood, the Journal of the American Society of Hematology.

24 May 2013

Smartphone solutions for clinical trials

mHealth broadly refers to the use of a mobile device to send patient information to or from a medical service provider. In most medication management mobile applications that are out there now, the “information” sent is usually a unidirectional nagging reminder to the patient. The application may populate a diary or it may not.

24 May 2013

New nano-sized needle can help study the effects of medicines on cells

Nano-sized needles developed by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim can force medicine into cells, even when the cell membranes offer resistance. The needles will make it easier to study the effects of medicines on cells.

24 May 2013

New, improved drugs can boost body's natural flu killer system

A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have shown recently that another, more promising, approach is to focus on improving drugs that boost the body's natural flu killer system.

24 May 2013

Senate immigration bill would ease restrictions on foreign health workers; Measure advances to increase scrutiny on compounding pharmacies

On Capitol Hill, several legislative efforts are moving forward on health issues. Among them is an effort by the Massachusetts delegation to keep bonus Medicare payments for the state's hospitals, while House Republicans are looking for another way to deal with a bill to fund high-risk insurance pools.

24 May 2013

EGFR gums up cell's miRNA-processing machinery under oxygen starvation conditions

Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs before it's dissolved, researchers reported in an early online publication at Nature.

24 May 2013

Viewpoints: Sen. Alexander sees reflections of Oliver North in Sebelius' quest to raise funds; vaccine scare's legacy

Major news outlets in recent days have reported that U.S. Department of Health and Human Services Secretary Kathleen Sebelius is raising money from the private sector -- including from health care executives -- for use by a private entity that is helping to implement ObamaCare. ... Is Ms. Sebelius raising funds for a private entity and then coordinating with that entity to do something Congress has refused to authorize, or for which it has refused to appropriate funds?

24 May 2013

Promising approach to prevent emergence of drug-resistant forms of cancer

Re-routing anti-cancer drugs to the "power plants" that make energy to keep cells alive is a promising but long-neglected approach to preventing emergence of the drug-resistant forms of cancer - source of a serious medical problem, scientists are reporting.

24 May 2013

Researchers explore targeted therapies for prostate cancer

Are certain drugs more effective against some types of prostate cancers than others? Researchers know that not all therapies work for all patients – the next question is to figure out how to match the right treatments with the right patients.

24 May 2013

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines for the treatment of viral infections, today announced that it has initiated dosing in a Phase I study of SB 9200, its investigational, once daily, oral therapy for the treatment of HCV infection.

24 May 2013

Drug addiction can be visualized in specific regions of brain that determine decision-making

New research shows that craving drugs such as nicotine can be visualized in specific regions of the brain that are implicated in determining the value of actions, in planning actions and in motivation.

24 May 2013

Combination of EEG and fMRI leads to improved treatment of patients with epilepsy

New techniques in imaging of brain activity developed by Jean Gotman, from McGill University's Montreal Neurological Institute, and his colleagues lead to improved treatment of patients suffering from epilepsy.

24 May 2013

Most residents dissatisfied with quality of substance-abuse training, survey finds

A 2012 survey of internal medicine residents at Massachusetts General Hospital (MGH) - one of the nation's leading teaching hospitals - found that more than half rated the training they had received in addiction and other substance use disorders as fair or poor.

24 May 2013

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

23 May 2013

Drugs News and Research

Fraunhofer FIT develops new Zeta software for cell division analysis

Sinovac Beijing receives GMP certificate for its proprietary vaccines

Scientists develop new device to test the effects of drugs

TSRI scientists devise new technique to find therapeutic antibodies

Mayo experts provide tips to prevent teen suicide

New research identifies mechanism to make cancer cells respond to chemotherapy

Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

Smartphone solutions for clinical trials

New nano-sized needle can help study the effects of medicines on cells

New, improved drugs can boost body's natural flu killer system

Senate immigration bill would ease restrictions on foreign health workers; Measure advances to increase scrutiny on compounding pharmacies

EGFR gums up cell's miRNA-processing machinery under oxygen starvation conditions

Viewpoints: Sen. Alexander sees reflections of Oliver North in Sebelius' quest to raise funds; vaccine scare's legacy

Promising approach to prevent emergence of drug-resistant forms of cancer

Researchers explore targeted therapies for prostate cancer

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Drug addiction can be visualized in specific regions of brain that determine decision-making

Combination of EEG and fMRI leads to improved treatment of patients with epilepsy

Most residents dissatisfied with quality of substance-abuse training, survey finds

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News